Other Species / Isoforms
  FRS2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T49-p
DTELILYtRKRDSVK
0 1
FRS2 (human) DTELILYtRKRDSVK T49-p
FRS2 (mouse) DTELILYTRKRDSVK T49
FRS2 (rat) DTELILYTRKRDSVK T49
Y59-p
RDSVKWHyLCLRRYG
0 1
FRS2 (human) RDSVKWHyLCLRRYG Y59-p
FRS2 (mouse) RDSVKWHYLCLRRYG Y59
FRS2 (rat) RDSVKWHYLCLRRYG Y59
S109-p
QEIMQNNsINVVEEP
0 1
FRS2 (human) QEIMQNNsINVVEEP S109-p
FRS2 (mouse) QEIMQNNSINVVEEP S109
FRS2 (rat) QEIMQNNSINVVEEP S109
T125-p
VERNNHQtELEVPRt
0 21
FRS2 (human) VERNNHQtELEVPRt T125-p
FRS2 (mouse) VERSSHQTELEVPRt T125
FRS2 (rat) VERNSHQTELEVPRt T125
T132-p
tELEVPRtPRtPttP
0 37
FRS2 (human) tELEVPRtPRtPttP T132-p
FRS2 (mouse) TELEVPRtPRtPttP T132-p
FRS2 (rat) TELEVPRtPRtPTtP T132-p
T135-p
EVPRtPRtPttPGFA
0 39
FRS2 (human) EVPRtPRtPttPGFA T135-p
FRS2 (mouse) EVPRtPRtPttPGLG T135-p
FRS2 (rat) EVPRtPRtPTtPGLG T135-p
T137-p
PRtPRtPttPGFAAQ
0 11
FRS2 (human) PRtPRtPttPGFAAQ T137-p
FRS2 (mouse) PRtPRtPttPGLGAQ T137-p
FRS2 (rat) PRtPRtPTtPGLGAQ T137
T138-p
RtPRtPttPGFAAQN
0 23
FRS2 (human) RtPRtPttPGFAAQN T138-p
FRS2 (mouse) RtPRtPttPGLGAQN T138-p
FRS2 (rat) RtPRtPTtPGLGAQS T138-p
Y150-p
AQNLPNGyPRyPsFG
0 2
FRS2 (human) AQNLPNGyPRyPsFG Y150-p
FRS2 (mouse) AQNLPNGyPRYPsFG Y150-p
FRS2 (rat) AQSLPNGYPRYPSFG Y150
Y153-p
LPNGyPRyPsFGDAS
0 2
FRS2 (human) LPNGyPRyPsFGDAS Y153-p
FRS2 (mouse) LPNGyPRYPsFGDAS Y153
FRS2 (rat) LPNGYPRYPSFGDAS Y153
S155-p
NGyPRyPsFGDASSH
Upstream
0 3
Treatment
  • angiotensin_2
  • SII_angiotensin_2
FRS2 (human) NGyPRyPsFGDASSH S155-p
FRS2 (mouse) NGyPRYPsFGDASSH S155-p
FRS2 (rat) NGYPRYPSFGDASSH S155
S169-p
HPSSRHPsVGSARLP
0 3
FRS2 (human) HPSSRHPsVGSARLP S169-p
FRS2 (mouse) HPSSRHPsVGsARLP S169-p
FRS2 (rat) HPSSRHPSVGSARLP S169
S172
SRHPsVGSARLPsVG
0 1
FRS2 (human) SRHPsVGSARLPsVG S172
FRS2 (mouse) SRHPsVGsARLPsVG S172-p
FRS2 (rat) SRHPSVGSARLPSVG S172
S177-p
VGSARLPsVGEEStH
0 23
FRS2 (human) VGSARLPsVGEEStH S177-p
FRS2 (mouse) VGsARLPsVGEESTH S177-p
FRS2 (rat) VGSARLPSVGEESTH S177
T183-p
PsVGEEStHPLLVAE
0 2
FRS2 (human) PsVGEEStHPLLVAE T183-p
FRS2 (mouse) PsVGEESTHPLLVAE T183
FRS2 (rat) PSVGEESTHPLLVAE T183
Y196-p
AEEQVHTyVNTtGVQ
Upstream
Downstream
5 11
FRS2 (human)
Y196-p
FRS2 (mouse)
Y196-p
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
Effects on Biological Processes:
  • cell differentiation, induced
  • endocytosis, inhibited
Treatment
  • KGF
  • serum_starvation
  • virus infection
FRS2 (human) AEEQVHTyVNTtGVQ Y196-p
FRS2 (mouse) AEEQVHTyVNTTGVQ Y196-p
FRS2 (rat) AEEQVHTYVNTTGVQ Y196
T200-p
VHTyVNTtGVQEERK
0 1
FRS2 (human) VHTyVNTtGVQEERK T200-p
FRS2 (mouse) VHTyVNTTGVQEERK T200
FRS2 (rat) VHTYVNTTGVQEERK T200
S211-p
EERKNRTsVHVPLEA
0 5
FRS2 (human) EERKNRTsVHVPLEA S211-p
FRS2 (mouse) EERKNRAsVHVPPEA S211-p
FRS2 (rat) EERKNRASVHIPPEA S211
S221-p
VPLEARVsNAESstP
0 4
FRS2 (human) VPLEARVsNAESstP S221-p
FRS2 (mouse) VPPEARVSNAESNtP S221
FRS2 (rat) IPPEARVSNAESNTP S221
S226-p
RVsNAESstPKEEPS
0 5
FRS2 (human) RVsNAESstPKEEPS S226-p
FRS2 (mouse) RVSNAESNtPKEEPS N226
FRS2 (rat) RVSNAESNTPKEEPS N226
T227-p
VsNAESstPKEEPSS
Upstream
0 9
Treatment
  • selumetinib
  • vemurafenib
FRS2 (human) VsNAESstPKEEPSS T227-p
FRS2 (mouse) VSNAESNtPKEEPSN T227-p
FRS2 (rat) VSNAESNTPKEEPSN T227
K267-ub
KQLMEKEkLEQLGRD
0 1
FRS2 (human) KQLMEKEkLEQLGRD K267-ub
FRS2 (mouse) KQLMEKEKLEQLGKD K267
FRS2 (rat) KQLMEKEKLEQLGKD K267
Y290-p
NTEWDTGyDsDERRD
0 1
FRS2 (human) NTEWDTGyDsDERRD Y290-p
FRS2 (mouse) NTEWDTGYDsDERRD Y290
FRS2 (rat) STEWDTGYDSDERRD Y290
S292-p
EWDTGyDsDERRDAP
0 5
FRS2 (human) EWDTGyDsDERRDAP S292-p
FRS2 (mouse) EWDTGYDsDERRDVP S292-p
FRS2 (rat) EWDTGYDSDERRDVP S292
S300-p
DERRDAPsVNKLVyE
0 1
FRS2 (human) DERRDAPsVNKLVyE S300-p
FRS2 (mouse) DERRDVPPVNKLVyE P300
FRS2 (rat) DERRDVPPVNKLVyE P300
Y306-p
PsVNKLVyENINGLs
Upstream
Downstream
3 226
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
Treatment
  • ephrin_B1
  • Su11274
FRS2 (human) PsVNKLVyENINGLs Y306-p
FRS2 (mouse) PPVNKLVyENINGLS Y306-p
FRS2 (rat) PPVNKLVyENINGLS Y306-p
S313-p
yENINGLsIPSASGV
0 1
FRS2 (human) yENINGLsIPSASGV S313-p
FRS2 (mouse) yENINGLSIPSASGV S313
FRS2 (rat) yENINGLSIPSASGV S313
T326-p
GVRRGRLtstsTSDT
0 4
FRS2 (human) GVRRGRLtstsTSDT T326-p
FRS2 (mouse) GVRRGRLTstStsDT T326
FRS2 (rat) GVRRGRLTSTSTSDT T326
S327-p
VRRGRLtstsTSDTQ
Upstream
0 56
Treatment
  • Su11274
  • U0126
FRS2 (human) VRRGRLtstsTSDTQ S327-p
FRS2 (mouse) VRRGRLTstStsDTQ S327-p
FRS2 (rat) VRRGRLTSTSTSDTQ S327
T328-p
RRGRLtstsTSDTQN
0 13
FRS2 (human) RRGRLtstsTSDTQN T328-p
FRS2 (mouse) RRGRLTstStsDTQN T328-p
FRS2 (rat) RRGRLTSTSTSDTQN T328
S329-p
RGRLtstsTSDTQNI
0 1
FRS2 (human) RGRLtstsTSDTQNI S329-p
FRS2 (mouse) RGRLTstStsDTQNI S329
FRS2 (rat) RGRLTSTSTSDTQNI S329
T330
GRLtstsTSDTQNIN
0 1
FRS2 (human) GRLtstsTSDTQNIN T330
FRS2 (mouse) GRLTstStsDTQNIN T330-p
FRS2 (rat) GRLTSTSTSDTQNIN T330
S331
RLtstsTSDTQNINN
0 1
FRS2 (human) RLtstsTSDTQNINN S331
FRS2 (mouse) RLTstStsDTQNINN S331-p
FRS2 (rat) RLTSTSTSDTQNINN S331
T344-p
NNSAQRRtALLNyEN
0 9
FRS2 (human) NNSAQRRtALLNyEN T344-p
FRS2 (mouse) NNSAQRRPALLNyEN P344
FRS2 (rat) NNSAQRRPALLNyEN P344
Y349-p
RRtALLNyENLPsLP
Upstream
Downstream
3 99
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
Treatment
  • ephrin_B1
  • Su11274
FRS2 (human) RRtALLNyENLPsLP Y349-p
FRS2 (mouse) RRPALLNyENLPsLP Y349-p
FRS2 (rat) RRPALLNyENLPSLP Y349-p
S354-p
LNyENLPsLPPVWEA
Upstream
0 7
Treatment
  • ischemia
FRS2 (human) LNyENLPsLPPVWEA S354-p
FRS2 (mouse) LNyENLPsLPPVWEA S354-p
FRS2 (rat) LNyENLPSLPPVWEA S354
S365-p
VWEARKLsRDEDDNL
Upstream
0 13
Treatment
  • ischemia
FRS2 (human) VWEARKLsRDEDDNL S365-p
FRS2 (mouse) VWEARKLsRDEDDNL S365-p
FRS2 (rat) VWEARKLsRDEDDNL S365-p
T376
DDNLGPKTPsLNGYH
0 1
FRS2 (human) DDNLGPKTPsLNGYH T376
FRS2 (mouse) DDNLGPKtPSLNGYH T376-p
FRS2 (rat) DDNLGPKTPSLNGYH T376
S378-p
NLGPKTPsLNGYHNN
0 1
FRS2 (human) NLGPKTPsLNGYHNN S378-p
FRS2 (mouse) NLGPKtPSLNGYHNN S378
FRS2 (rat) NLGPKTPSLNGYHNN S378
Y392-p
NLDPMHNyVNtENVT
Downstream
3 28
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
FRS2 (human) NLDPMHNyVNtENVT Y392-p
FRS2 (mouse) NLDPMHNyVNTENVT Y392-p
FRS2 (rat) NLDPMHNYVNTENVT Y392
T395-p
PMHNyVNtENVTVPA
0 2
FRS2 (human) PMHNyVNtENVTVPA T395-p
FRS2 (mouse) PMHNyVNTENVTVPA T395
FRS2 (rat) PMHNYVNTENVTVPA T395
S403-p
ENVTVPAsAHKIEYS
0 6
FRS2 (human) ENVTVPAsAHKIEYS S403-p
FRS2 (mouse) ENVTVPAsAHKIDYS S403-p
FRS2 (rat) ENVTVPASAHKIDCS S403
S428-p
NFDIRRPsLEHRQLN
Upstream
0 8
Treatment
  • ischemia
FRS2 (human) NFDIRRPsLEHRQLN S428-p
FRS2 (mouse) NFDIRRPsLEHRQLN S428-p
FRS2 (rat) NFDIRRPsLEHRQLN S428-p
Y436-p
LEHRQLNyIQVDLEG
Downstream
3 0
FRS2 (human)
Y436-p
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
FRS2 (human) LEHRQLNyIQVDLEG Y436-p
FRS2 (mouse) LEHRQLNyIQVDLEG Y436-p
FRS2 (rat) LEHRQLNYIQVDLEG Y436
S445-p
QVDLEGGsDsDNPQT
0 1
FRS2 (human) QVDLEGGsDsDNPQT S445-p
FRS2 (mouse) QVDLEGGSDSDNPQT S445
FRS2 (rat) QVDLEGGSDSDNPQT S445
S447-p
DLEGGsDsDNPQTPK
0 1
FRS2 (human) DLEGGsDsDNPQTPK S447-p
FRS2 (mouse) DLEGGSDSDNPQTPK S447
FRS2 (rat) DLEGGSDSDNPQTPK S447
T455-p
DNPQTPKtPttPLPQ
0 3
FRS2 (human) DNPQTPKtPttPLPQ T455-p
FRS2 (mouse) DNPQTPKTPTTPLPQ T455
FRS2 (rat) DNPQTPKTPTTPLPQ T455
T457-p
PQTPKtPttPLPQtP
0 1
FRS2 (human) PQTPKtPttPLPQtP T457-p
FRS2 (mouse) PQTPKTPTTPLPQtP T457
FRS2 (rat) PQTPKTPTTPLPQTP T457
T458-p
QTPKtPttPLPQtPt
0 5
FRS2 (human) QTPKtPttPLPQtPt T458-p
FRS2 (mouse) QTPKTPTTPLPQtPT T458
FRS2 (rat) QTPKTPTTPLPQTPT T458
T463-p
PttPLPQtPtRRtEL
0 10
FRS2 (human) PttPLPQtPtRRtEL T463-p
FRS2 (mouse) PTTPLPQtPTRRTEL T463-p
FRS2 (rat) PTTPLPQTPTRRTEL T463
T465-p
tPLPQtPtRRtELyA
0 1
FRS2 (human) tPLPQtPtRRtELyA T465-p
FRS2 (mouse) TPLPQtPTRRTELyA T465
FRS2 (rat) TPLPQTPTRRTELYA T465
T468-p
PQtPtRRtELyAVID
0 1
FRS2 (human) PQtPtRRtELyAVID T468-p
FRS2 (mouse) PQtPTRRTELyAVID T468
FRS2 (rat) PQTPTRRTELYAVID T468
Y471-p
PtRRtELyAVIDIER
Downstream
2 17
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell differentiation, induced
FRS2 (human) PtRRtELyAVIDIER Y471-p
FRS2 (mouse) PTRRTELyAVIDIER Y471-p
FRS2 (rat) PTRRTELYAVIDIER Y471
T499-p
DDGTSRKtRHNstDL
0 1
FRS2 (human) DDGTSRKtRHNstDL T499-p
FRS2 (mouse) DDGTSRKTRHNstDL T499
FRS2 (rat) DDGTSRKTRHNSTDL T499
S503-p
SRKtRHNstDLPM__
Upstream
0 20
Treatment
  • gefitinib
  • U0126
FRS2 (human) SRKtRHNstDLPM__ S503-p
FRS2 (mouse) SRKTRHNstDLPM__ S503-p
FRS2 (rat) SRKTRHNSTDLPM__ S503
T504-p
RKtRHNstDLPM___
0 11
FRS2 (human) RKtRHNstDLPM___ T504-p
FRS2 (mouse) RKTRHNstDLPM___ T504-p
FRS2 (rat) RKTRHNSTDLPM___ T504